Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevoflurane and Desflurane on Clara Cell Protein in Liver Donors
NCT04645316Completed
- Sponsor
- Inonu University
- Start
- Nov 2020
- Primary completion
- Jun 2021
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
Randomised trial of sevoflurane and desflurane in not applicable; "lung injury" is not a specific disease, sponsored by Inonu University. Primary endpoint: Clara cell protein blood levels at 6 hours. Started Nov 2020; status: completed.
02
Drugs
sevofluranedesflurane
03
Conditions
not applicable; "lung injury" is not a specific disease
Beyond the preview
Go deeper on NCT04645316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04645316.